STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Industrials Industrial Machinery
trading-chart-2

Honeywell Expands Aerospace Portfolio with $1.9 Billion CAES Acquisition

byLiliana Vida
June 20, 2024
in Industrial Machinery, Large-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

Strategic Buy Enhances Defense Technology Capabilities Amid Global Tensions

Honeywell (HON) has announced its agreement to acquire CAES Systems, an aerospace and defense technology company, for $1.9 billion in an all-cash transaction from private equity firm Advent International. This acquisition is Honeywell’s third this year and is set to significantly enhance its aerospace technologies division.

CAES Systems, known for its development of sophisticated electronics including antenna systems and communication networks, serves major aerospace and defense clients. This acquisition aligns with Honeywell’s strategic focus on bolstering its capabilities across various domains including land, sea, air, and space. The move comes at a time when defense contractors are experiencing a surge in orders due to prolonged global conflicts, such as the Russian invasion of Ukraine and the ongoing war in Gaza.

Honeywell Aerospace Technologies President and CEO, Jim Currier, emphasized the strategic importance of this acquisition, stating, “CAES’ trusted position with top U.S. defense customers strengthens our existing relationships.” The acquisition is expected to improve and expand Honeywell’s offerings, reinforcing its position in the defense sector.

In October 2023, Honeywell initiated a strategic realignment to concentrate on key megatrends like automation, aviation, and energy transition. This acquisition supports that vision by adding approximately 2,200 employees, many of whom are highly skilled engineers, and providing additional automated facilities to Honeywell’s portfolio.

The deal is poised to close in the second half of 2024, with Honeywell projecting an increase in adjusted earnings per share within the first full year post-acquisition. This is part of Honeywell’s broader strategy to grow through mergers and acquisitions, focusing on high-performing segments while divesting units that do not align with its growth trajectory.

Over the past few years, Honeywell has been actively pursuing acquisitions to fortify its market position in key sectors. The addition of CAES Systems is expected to enhance Honeywell’s technological edge and operational capabilities, offering advanced solutions to meet the evolving needs of defense and aerospace customers.

In conclusion, Honeywell’s acquisition of CAES Systems marks a significant step in its ongoing efforts to enhance its aerospace technology capabilities. As global defense needs continue to rise, this strategic move positions Honeywell to better serve its customers with cutting-edge technologies and innovative solutions, solidifying its status as a leader in the aerospace and defense industry.

Read original press release:here

You might like this article: Berkshire Hathaway Increases Stake in Occidental Petroleum to Nearly 29%

Tags: GrowthM&AMoversNewsStock Market
Previous Post

Berkshire Hathaway Increases Stake in Occidental Petroleum to Nearly 29%

Next Post

Starlab Space Partners with Palantir Technologies to Revolutionize Commercial Space Station Operations

Related Posts

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

byLuca Blaumann
August 7, 2025
0

Zepbound and Mounjaro Drive U.S. Sales, Yet Orforglipron Trial Results Raise Investor Concerns Eli Lilly (LLY) delivered a solid second-quarter...

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

byLuca Blaumann
August 6, 2025
0

Cosmetics giant sees 30% profit drop as China duties weigh on bottom line, even as revenue and product innovation remain...

trading-chart-2

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

byLiliana Vida
August 4, 2025
0

AI-driven growth, strong U.S. contracts, and Trump’s cost-cutting push propel Palantir into the top 10 U.S. tech companies by market...

Next Post
trading-chart

Starlab Space Partners with Palantir Technologies to Revolutionize Commercial Space Station Operations

Latest News

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast

Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Based on Your Interest

tesla
Artificial Intelligence

Tesla Board Approves $29 Billion Alternative Compensation Plan for Elon Musk

August 4, 2025
evtol
Aerospace & Defense

Blade Air Mobility Sells Rideshare Business to Joby Aviation for $125 Million

August 4, 2025
trading-chart-2
Large-Cap

Qualcomm Posts Strong Q3 Results, Fueled by Automotive and IoT Growth

July 30, 2025

Recommended

Aerospace & Defense

Palo Alto Networks Eyes $20B Deal for CyberArk

July 29, 2025
Ecommerece

AMD and Amazon: Two Titans Poised for Explosive Growth

July 28, 2025
Entertainment

FCC Approves $8B Paramount-Skydance Merger Amid Political Controversy

July 25, 2025
Aerospace & Defense

FAA Keeps Boeing 737 MAX Production Cap in Place Amid Ongoing Oversight

July 24, 2025
Large-Cap

Intel Beats on Revenue, Misses on Earnings; Cuts Workforce by 15%

July 24, 2025
Stoxpo

Follow us on social media:

Highlights

  • Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock
  • Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light
  • Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations
  • Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
  • Palantir Surges Past $1 Billion Quarterly Revenue, Lifts Guidance Amid AI Boom

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock

August 7, 2025

Daxor’s New Handheld Blood Volume Analyzer Gets FDA Green Light

August 7, 2025

Tariffs Dull E.l.f. Beauty’s Shine Despite Beating Expectations

August 6, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?